Chroma Medicine

Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, to deliver new treatments for patients with serious diseases. Chroma’s epigenetic editors can precisely and durably control gene expression without cutting or mutating the DNA.

Headquarters Cambridge, MA
Pipeline Status Preclinical
Twitter @chromamedicine
LinkedIn Chroma Medicine